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AbstrACt 
Objectives Healthcare is a complex system, so 
quality improvement will commonly lead to unintended 
consequences which are rarely evaluated. In previous 
qualitative work, we proposed a framework for 
considering the range of these potential consequences, 
in terms of their desirability and the extent to which 
they were predictable or expected during planning. 
This paper elaborates on the previous findings, using 
consensus methods to examine what consequences 
should be identified, why and how to prioritise, evaluate 
and interpret all identified consequences, and what 
stakeholders should be involved throughout this process.
Design Two-round modified Delphi consensus study.
setting and participants Both rounds were completed 
by 60 panellists from an academic, clinical or 
management background and experience in designing, 
implementing or evaluating quality improvement 
programmes.
results Panellists agreed that trade-offs (expected 
undesirable consequences) and unpleasant 
surprises (unexpected undesirable consequences) 
should be actively considered. Measurement of 
harmful consequences for patients, and those with 
high workload or financial impact was prioritised, 
and their evaluation could also involve the use of 
qualitative methods. Clinical teams were agreed as 
important to involve at all stages, from identifying 
potential consequences, prioritising which of those 
to systematically evaluate, undertaking appropriate 
evaluation and interpreting the findings. Patients were 
necessary in identifying consequences, managers in 
identifying and prioritising, and improvement advisors 
in interpreting the data.
Conclusion There was consensus that a balanced 
approach to considering all the consequences of 
improvement can be achieved by carefully considering 
predictable trade-offs from the outset and deliberately 
pausing after implementation to identify any unexpected 
surprises and make an informed decision as to whether 
quantitative or qualitative evaluation is needed and 
feasible. Stakeholders’ roles in in the process of 
identifying, prioritising, evaluating and interpreting 
potential consequences should be explicitly addressed 
within planning and revisited during and after 
implementation.
bACkgrOunD  
The complexity of the healthcare system, 
along with the multiple pressures it faces, 
means that eﬀorts to improve quality 
and safety often achieve only limited 
beneﬁts and can have unintended conse-
quences,1 (Manojlovich, 2016 #19; Merton, 
1936, The Unanticipated Consequences of 
Purposive Social Action) which may impact 
positively or negatively on care processes 
and outcomes. However, several systematic 
reviews have shown that most papers eval-
uating quality improvement programmes 
mainly report impact on targeted goals, 
with minimal reporting of other unintended 
consequences.2 3 For example, only 1 of 121 
interventions aiming to reduce falls and cath-
eter-related infections,4 none of 34 studies 
strengths and limitations of this study
 ► To the best of our knowledge, this will be the first 
study to generate Delphi-based expert consensus 
on the identification, prioritisation, evaluation and 
interpretation of a wide range of quality improve-
ment consequences, an area that has been largely 
overlooked in the existing literature.
 ► This study provides insights into how a balanced 
approach to determining all consequences of quality 
improvement projects can be achieved, the specif-
ic factors that need to be considered and the stage 
at which relevant stakeholders can be actively 
involved.
 ► The Delphi panel was purposively selected with the 
majority of participants identifying themselves as 
academics, quality improvement advisors and pro-
viders of healthcare services across the UK, with 
experience of designing, implementing or evaluating 
quality improvement interventions.
 ► Although the selection of experts was appropriate 
for the purpose of this study, the answers provided 
may not be appropriate for all practice settings, and 
therefore might limit the generalisability of our find-
ings beyond the UK healthcare system.
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of improvement interventions to improve surgical care,5 
only 6 of 94 (6.4%) studies examining the application 
of Plan Do Study Act improvement methods6 and only 
1 of 100 perioperative care improvement interventions 
reported any impact on unintended consequences.7 
Furthermore, improvement projects rarely evaluate 
consequences identified after full implementation.3 A 
recent Cochrane review of interventions to improve anti-
biotic prescribing practices for hospital inpatients showed 
that only 11 (10%) of 110 studies reporting interrupted 
time series data of improvement interventions (which 
typically evaluated healthcare rather than research inter-
ventions) reported any data about unintended negative 
consequences.8 Overall, while there are a number of 
recommendations for systematically designing quality 
improvement interventions,9–11 there is a lack of evidence 
that improvement programmes routinely evaluate the 
presence of unintended consequences either preimple-
mentation or postimplementation,12–15 with little specific 
guidance on how to best account for improvement conse-
quences other than goals and what potential stakeholders 
should be consulted in planning, conducting and inter-
preting evaluations.
We have previously conducted a qualitative analysis 
of data from 15 semistructured interviews and 2 focus 
groups with 24 experts to explore the current under-
standing of unintended consequences of quality improve-
ment.2 Based on the findings of this analysis, we proposed 
a structured framework for considering the range of 
potential consequences of improvement interventions, in 
terms of their desirability and the extent to which they 
were expected during the initial planning. As described 
in figure 1, the framework proposes that a balanced 
approach should consider goals (expected desirable 
consequences) and predictable trade-offs (expected 
undesirable consequences) early in the design of a quality 
improvement programme and pause to identify and take 
stock of pleasant (unexpected desirable consequences) 
and unpleasant surprises (unexpected undesirable conse-
quences) after a period of implementation.
Framed by our previous qualitative work,2 3 this paper 
aims to:
1. Validate the previously developed framework and, 
through expert consensus, establish what poten-
tial quality improvement consequences should be 
identified.
Figure 1 A framework describing different types of consequences of quality improvement projects (derived from previous 
qualitative work and wider literature, and validated through a two-round consensus study).
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2. Extend the framework wider applicability within the 
quality improvement measurement context, by explor-
ing and developing consensus in relation to why and 
how to prioritise, evaluate and interpret all identified 
consequences and what stakeholders should be in-
volved throughout this process.
MethODs
study design
The well-established consensus process incorporated a 
two-round modified Delphi method,16 which consisted of 
rating and ranking of the importance of various propo-
sitions whose focus and scope were determined through 
the framework developed in our previous qualitative 
study.2 The modified Delphi process was chosen as it is 
recommended for use in the field of quality improvement 
and patient safety as a reliable means of determining 
consensus for a defined multifactorial and complex 
problem. It is also useful in minimising the impact of 
group interaction and influence, as well as using valuable 
expert knowledge where understanding is only partial or 
incomplete.17
the development of the Delphi survey
Four key survey sections were defined as follows:
Section 1: Identifying potential consequences of 
improvement: Delphi panellists were asked what types 
of improvement consequences should be identified and 
who should be involved in identifying them.
Section 2: Prioritising which identified consequences to 
systematically evaluate: Panellists were asked under what 
circumstances should evaluation be conducted to assess 
and/or explore any identified potential consequences, 
and who should be involved in this decision.
Section 3: Undertaking appropriate evaluation for any 
identified consequences. Panellists were asked to rate 
statements about how to appropriately evaluate conse-
quences of improvement, and who should be involved in 
this.
Section 4: Interpreting the emerging data: Panel-
lists were asked to rate statements about who should be 
involved in understanding and interpreting findings to 
inform potential action.
Delphi survey piloting
Draft statements were initially pretested by a group of 
10 clinical academics who commented on clarity and 
appropriateness, followed by two rounds of piloting by 
14 additional participants with similar academic, clin-
ical or management background as the targeted sample, 
using the same open access web platform (Bristol Online 
Surveys) as the main study. Pretesting and piloting led 
to some additional statements being proposed and 
added, and to refine the survey in terms of wording and 
sequencing.
Panel selection and recruitment
The main study panel members were purposively 
selected to be individuals with experience of designing, 
implementing or evaluating quality improvement inter-
ventions with an academic, clinical or management back-
ground. We generated a list of experts by including all 
the stakeholders approached for the original qualitative 
study,2 plus additional improvement advisors, clinical 
academics, providers of health and social care services, 
policy-makers and patient representatives identified from 
online searches of articles with the highest number of 
citations in two leading quality improvement journals, 
authors of policy documents setting the general direc-
tion of quality improvement, keynote speakers at relevant 
conferences in the field, members of established quality 
improvement partnerships, service users attending 
community groups to advise local health boards and the 
research team’s own networks. Additional Delphi invi-
tees were identified through a snowballing technique,18 
whereby contacted panellists proposed suitable others 
with similar experience and knowledge.
Data collection
Consistent with consensus development procedures,17 we 
used sequential, iterative stages as follows.
Delphi round 1
Participants were invited to take part by a personalised 
email which included a weblink to the round 1 online 
questionnaire, a letter of invitation to participate, the 
study information sheet and a briefing paper explaining 
the development process and theoretical underpinnings 
(online supplementary appendix 1). Participants were 
asked to score statements using a five-point Likert scale 
with a neutral option, ranging from ‘not at all important’ 
to ‘extremely important’. The type of Likert scales 
normally varies from study to study; however, the five-
point Likert scale has been the most consistently used 
as an acceptable compromise between the conflicting 
goals of offering enough choice to measure strength of 
opinion and designing items that are readily compre-
hensible to respondents.19 Furthermore, five-point Likert 
scales represent a valid and reliable mean of measuring 
different levels of item agreement or assigned impor-
tance across similar modified Delphi studies.20
Space for free-text comments about existing statements 
was also given in the questionnaire, including justification 
for response and/or any other important areas which 
were not addressed. The survey also included open-ended 
questions for structured elicitation and demographic 
information relating to participants’ role and experience.
Delphi round 2
Participants from round 1 were sent a revised briefing 
paper (online supplementary appendix 2) along with 
feedback on their scores on each statement compared 
with the distribution of all scores (online supplementary 
appendix 3). Given that there were no significant differ-
ences in scoring associated with any of the participant 
characteristics examined in round 1 (eg, geographical 
location, roles or experience), feedback was presented in 
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a combined form. This is consistent with previous litera-
ture which shows that if agreement is already satisfactory 
between stakeholder groups, then the type of feedback 
given may not make any difference in terms of the 
number of outcomes retained or reducing the variability 
of opinion.21
Using the same voting method as round 1, participants 
were subsequently asked to complete a revised question-
naire (online supplementary appendix 4) which included 
notes to indicate what and where changes had been made 
in response to all round 1 comments. Example of changes 
included removing examples which were ambiguous and 
clarifying and amending the wording of some statements 
(online supplementary appendix 5). Participants were 
given 1 month to complete each round of the survey and 
a reminder letter was sent via email to everyone who had 
not replied within 14 days.
Data analysis and definition of consensus
There is no accepted, set standard for the target 
percentage of agreement, with thresholds and defini-
tions of consensus ranging between 51% and 80%.22 23 
We chose to take a conservative approach to defining 
consensus, deeming it to be present if ≥80% of partici-
pants rated each individual statement as very important 
or extremely important on the five-point Likert scale. All 
data entered via the web platform were downloaded and 
analysed using SPSS V.21.0 to calculate frequencies and 
mean ratings. The synthesis and thematic analysis of free-
text responses was undertaken in NVivo V.11 following 
each round. After coding the initial sets of responses, MT 
and BG met to compare the labels attached and agreed 
on a set of codes that MT applied to all subsequent data. 
The wider team also convened regularly to discuss the 
summaries of any emerging findings. The focus of the 
analysis presented in the paper is the round 2 quantitative 
responses and supporting free-text findings.
results
Panel characteristics
We attempted to email 180 individuals, with 170 emails 
delivered successfully. Seventy-two (42.4%) individ-
uals completed the round 1, and of these, 60 (83.3%) 
completed round 2. Table 1 shows that 50 (83.3%) of the 
60 participants completing both rounds worked in the 
UK, 8 (13.3%) worked in another European country and 
2 (3.3%) worked in the USA. Participants had a variety 
of (often multiple) roles with 28 (46.6%) having an 
academic background and 26 (43.3%) currently working 
as improvement advisors. Despite our best efforts to opti-
mise recruitment and retention, only two panellists were 
providers of social care services (3.3%), two were patients 
or carers (3.3%) and one identified as a service user 
representative (1.6%).
Furthermore, more than half of the sample (53.4%) 
had 6 or more years’ experience of working in healthcare 
quality improvement while 31 (51.6%) reported to have 
undertaken formal training in this area, most commonly 
(16.6%) to become Institute for Healthcare Improve-
ment accredited improvement advisors. On the contrary, 
29 (48.3%) revealed little or no experience of systemati-
cally measuring unintended consequences.
seCtiOn 1: iDentifying POtentiAl COnsequenCes Of 
iMPrOveMent
Table 2 shows that all participants rated measurement 
of predefined improvement goals as very important 
or extremely important. There was also consensus 
that measures are important for identifying trade-offs 
expected before the implementation (95% rated this as 
important or very important) or unpleasant surprises 
emerging after a period of implementation (90%). 
Although some participants valued pleasant surprises 
as being important, ratings of this statement (70%) did 
not achieve the prespecified consensus level, with some 
participants describing pleasant surprises as being less 
critical than other consequences in reaching a more 
balanced approach.
Improvement needs to be judged on its merits alone 
and an unpleasant surprise detracts from those mer-
its, but I am not sure whether a more pleasant sur-
prise necessarily augments them. Simply measuring 
everything in sight just in case it had a positive influ-
ence is neither desirable nor feasible and probably 
not the best use of resources. (Improvement advisor)
There was consensus that clinicians and non-clini-
cians who directly engage with patients in the targeted 
area (100%), patients (83%) and managerial staff 
(80%) involved in organising the targeted care should 
be involved in identifying all potential consequences of 
improvement activity (table 3).
section 2: prioritising which identified consequences to 
systematically evaluate
There was consensus that potential consequences should 
be measured if there was a likelihood for high (100%) 
and moderate harms (95%) to patients, followed by high 
(98%) or moderate (90%) negative workload impli-
cations for the service doing the improvement as well 
as high (95%) or moderate (85%) negative workload 
implications for other health and social care services. 
Consensus was also achieved for reasons including high 
(95%) and moderate negative financial implications 
(85%) for services within the area targeted for improve-
ment and high (88%) financial implications for services 
outside healthcare.
There was consensus about the importance of potential 
high benefits to patients (90%), to the service doing the 
improvement (95%) and to other health or social care 
services (81%), but not for matching moderate benefits 
(61%–75%), reinforcing the view that the occurrence of 
trade-offs and unpleasant surprises is probably the current 
focus when making informed decision as to whether 
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systematic evaluation is needed. No ‘low severity’ conse-
quences reached the agreed consensus level although, as 
explained by one participant, the perception of severity 
can sometimes be a subjective assessment:
What might appear trivial to an outsider like a 
one min increase in the time taken for clinical staff to 
do something might be perceived by the clinical staff 
as considerably longer and possibly with knock on 
consequences for scheduling of other tasks. Similarly, 
what might appear to an outsider to be minor in-
convenience for patients might be the last straw. 
(Policymaker and regulator)
Table 1 Demographics of the 60 participants completing both rounds of ratings
Panel composition N (%)
Geographical location
  UK (Scotland 39, England 8, Wales 2, Northern Ireland 1) 50 (83.3)
  Europe 8 (13.3)
  USA 2 (3.3)
Role within healthcare quality improvement*
  Academic research and/or teaching 28 (46.6)
  Quality improvement advisor 26 (43.3)
  Provider of healthcare services 11 (18.3)
  Managerial staff 6 (10.0)
  Policy-maker and regulator 4 (6.6)
  Provider of social care services 2 (3.3)
  Patient or carer 2 (3.3)
  Service user representative 1 (1.6)
Experience in working in quality improvement and patient safety
  No experience 5 (8.3)
  Less than 2 years 7 (11.7)
  2–5 years 16 (26.7)
  6–10 years 16 (26.7)
  11–15 years 7 (11.7)
  More than 15 years 9 (15.0)
Training in improvement science or quality improvement
  No 29 (48.4)
  Yes 31 (51.6)
If yes, then type of training attended† 
Institute of Healthcare Improvement-Improvement Advisor Development Program 10 (16.6) 
Lean or Lean Six Sigma Training Programme 5 (8.3) 
The Scottish Patient Safety Programme Fellowship 5 (8.3) 
Improvement Science Training for European Healthcare Workers 5 (8.3) 
Academic qualifications in quality improvement or implementation science 5 (8.3) 
Other training or fellowships (various) 11 (18.3) 
Experience of using balancing measures in quality improvement or patient safety
  No experience 20 (33.3)
  Less than 2 years 9 (15.0)
  2–5 years 14 (23.3)
  6–10 years 10 (16.7)
  11–15 years 2 (3.3)
  More than 15 years 5 (8.3)
*Number adds up to more than 60 because participants had the option to select multiple relevant roles.
 †Number adds up to more than 31 because participants had the option to select multiple relevant training. 
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Beyond effects on the quality of the service or the patient 
care, increasing staff engagement with the improvement 
activity (86%) and reducing staff resistance to change 
(85%) were additional reasons to evaluate outcomes, 
because it demonstrated that improvers were taking staff 
concerns seriously (table 4).
There was only consensus that clinical teams (96%) 
and managerial staff (83%) involved in delivering 
and organising the targeted care should be involved 
in prioritising whether the identified consequences 
are important enough to be evaluated systematically 
(table 3).
section 3: undertaking appropriate evaluation for any 
identified consequences
There was consensus that, irrespective of whether data are 
collected bespoke or for another purpose, both quantita-
tive (90%) and qualitative data (86%) could be used to 
evaluate trade-offs, pleasant and/or unpleasant surprises 
with the same rigour as evaluating the predefined 
improvement goals (table 5).
As one participant described, qualitative data have 
much to offer both for the identification of trade-offs 
before implementation, and supporting postimplementa-
tion reﬂection on surprises, especially when retrospective 
measurement is not feasible.
Numerical measures will be important for pre-identi-
fied consequences while qualitative data will be par-
ticularly important for identifying consequences that 
fall at the right-hand end of the expected-unexpected 
continuum. It is important to be curious and find a 
reliable mechanism for galvanising insights and sto-
ries that ultimately bring those conventional metrics 
alive (Improvement science academic)
There was only consensus that clinical teams delivering 
the targeted care (91%) should be involved in the imple-
mentation of appropriate evaluation for any identified 
consequences (table 3).
section 4: interpreting the emerging data
There was consensus that both clinical teams delivering 
the targeted care (86%) and improvement advisors 
(91%) should be involved in interpreting the data about 
unintended consequences (table 3). Panellists explained 
in their free-text comments how making more use of 
external expertise in interpreting the data could help 
make findings more meaningful and readily useful.
There is a need for the methodological expertise and 
critical distance of improvement advisors who can see 
data with fresh eyes. It may be more robust to have 
them interpret the data initially and then discuss the 
findings with other groups (Provider of healthcare 
services)
DisCussiOn
Overview of the main findings
Overall, there was consensus in the Delphi panel about 
the importance of the majority of the propositions. All 
participants rated measurement of predefined improve-
ment goals as important, and there was agreement that 
trade-offs and unpleasant surprises should be actively 
considered, but no consensus about pleasant surprises. 
Participants prioritised the evaluation of seriously 
harmful consequences for patients, and those with high 
workload or financial impact in both the local imple-
mentation context, and in other health and social care 
services. There was also consensus that evaluation of 
a wider range of consequences could have additional 
value in terms of increasing staff engagement with the 
improvement activity and reducing resistance to change 
irrespective of whether measurement led to any change 
in implementation. Participants agreed that both quan-
titative data and qualitative data were helpful to evaluate 
trade-offs and surprises, with free-text comments high-
lighting that qualitative data are often useful either to 
contextualise quantitative data or to understand impact 
when formal measurement is not feasible. Agreement 
about the importance of involving various internal and 
external stakeholders varied depending on the stage of 
the improvement work. Clinical teams delivering the 
targeted care were agreed to be necessary to involve 
in all stages from identifying potential consequences, 
prioritising which consequences to evaluate, under-
taking appropriate evaluation and interpreting the data. 
Patients were necessary in identifying potential conse-
quences of improvement activity, managers in identifying 
consequences and prioritising which of those have to be 
systematically evaluated, and improvement advisors in 
interpreting the emerging data.
strengths and limitations of the study
Strengths of the study are that it built on our previous 
qualitative work on this topic,2 3 that we recruited and 
retained a substantial expert panel with an 83.3% response 
rate between rounds thereby reducing attrition bias, and 
Table 2 All statements about the relative importance of all 
four types of improvement consequences, in descending 
order of average strength of agreement
% rating very 
or extremely 
important
Mean 
rating*
Improvement goals 100† 4.85†
Improvement trade-offs 95† 4.58†
Unpleasant surprises 90† 4.30†
Pleasant surprises 70 3.68
*1=not at all important, 2=slightly important, 
3=somewhat important, 4=very important, 5=extremely important.
†Indicates consensus among panellists meaning that ≥80% of 
participants rated a statement as very important and extremely 
important.
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Table 4 Statements about the relative importance of different reasons to evaluate any trade-offs, pleasant surprises and/or 
unpleasant surprises, in descending order of average strength of agreement
% rating very 
or extremely 
important*
Mean 
rating†
Potential high harm to patients (any serious harm such as death, or common significant harm such as 
recoverable injury)
100* 4.96*
High negative workload implications for the service doing the improvement (cannot accommodate 
without compromising other work)
98* 4.80*
High negative workload implications for other health or social care services (cannot accommodate 
without compromising other work)
95* 4.71*
High negative financial implications for healthcare services 95* 4.70*
Potential high benefits for the service doing the improvement (significant improvement in staff morale 
or high financial savings)
95* 4.63*
Potential moderate harm to patients 95* 4.58*
Potential high benefits to patients (major health improvements which are not related to the initial 
improvement goal)
90* 4.53*
Moderate negative workload implications for the service doing the improvement 90* 4.35*
High negative financial implications for services outside healthcare 88* 4.31*
Increasing staff engagement with the improvement activity 86* 4.46*
Reducing staff resistance to the improvement activity 85* 4.31*
Moderate negative workload implications for other health or social care services 85* 4.25*
Moderate negative financial implications for healthcare services 85* 4.28*
Potential high benefits for other health or social care services 81* 4.25*
Moderate negative financial implications for services outside healthcare 78 3.90
Potential moderate benefits for the service doing the improvement 75 4.05
Potential moderate benefits to patients 70 4.01
Potential moderate benefits for other health or social care services 61 3.73
Increasing staff ownership of data and measures 78 4.25
No ‘low severity’ consequences reached consensus, so these are not shown in the table.
*Indicates consensus among panellists meaning that ≥80% of participants rated a statement as very important and extremely important.
†1=not at all important, 2=slightly important, 3=somewhat important, 4=very important, 5=extremely important.
Table 5 All statements about the relative importance of undertaking appropriate evaluation, in descending order of average 
strength of agreement
% rating 
very or 
extremely 
important
Mean 
rating*
Use quantitative data to measure if trade-offs, pleasant and/or unpleasant surprises have occurred 90† 4.48
Use data (eg, qualitative, quantitative, already available or bespoke) to make evaluative judgements/
measure trade-offs, pleasant and/or unpleasant surprises with the same rigour as measuring 
improvement goals
88† 4.45
Use qualitative data to make evaluative judgements about the presence and extent of trade-offs, 
pleasant and/or unpleasant surprises
86† 4.41
Use bespoke data collection by clinical teams to measure trade-offs, pleasant and/or unpleasant 
surprises
46 4.13
Use data that is already collected for another purpose to measure trade-offs, pleasant and/or 
unpleasant surprises
41 4.05
*1=not at all important, 2=slightly important, 3=somewhat important, 4=very important, 5=extremely important.
†Indicates consensus among panellists meaning that ≥80% of participants rated a statement as very important and extremely important.
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that it used a predefined criterion to define agreement 
on the importance of a proposition. A potential weakness 
is that the round 1 questionnaire was structured by our 
qualitative work, meaning that there was less contribution 
from the Delphi panel in defining the scope of the prop-
ositions, although participants did have the opportunity 
to add, alter or comment on each section. Additionally, 
there are no generally accepted rules for how the pres-
ence of consensus should be defined, with several factors, 
such as the aim of research, number of respondents and 
sequence of rounds, influencing the cut-off chosen.22 23 
Given the exploratory nature of the study, we deliber-
ately chose to take a conservative approach to defining 
consensus, requiring ≥80% of participants to agree that 
proposition was very important or extremely important. 
An implication is that lack of consensus does not neces-
sarily mean lack of importance, and such propositions 
may be relevant under some but not all circumstances. 
We, therefore, report all results in detail, and others may 
choose to consider different cut-offs suitable for their 
purposes.
Lastly, four-fifths of participants were UK based and 
two-thirds Scotland based. The UK has a well-developed 
quality improvement infrastructure which does vary some-
what in the different UK countries, so panel composition 
may limit the generalisability of the findings. However, 
participants came from a variety of quality improvement, 
health service and academic backgrounds, and we believe 
that the problems, findings and recommendations 
described in this paper are likely have general application.
Patient and public involvement
The priorities, experience and preferences of the people 
who used the local services were represented through 
their participation in the individual and group inter-
views that informed this study,2 and their willingness to 
take part in piloting draft versions of the instrument 
and completing both rounds of the Delphi. However, 
we recognise that the final expert panel predominately 
consisted of academics, quality improvement advisors 
and providers of healthcare services. There is a need to 
engage a larger number of participants from outside the 
immediate word of frontline led to quality improvement, 
particularly service users, public, third sector partners and 
social care providers. However, this does not mean that 
everyone will choose to be involved to the same extent, 
or indeed will be responsible for planning, monitoring 
or evaluating care. We instead suggest moving beyond 
this narrow and exclusive approach,24 and engage in a 
critical appraisal of the focus, methods and benefits of 
involvement, regardless of whether participants are using 
or providing services.
implications for quality improvement programmes
The importance of balanced measurement systems is 
well established, with Drucker making the case for this 
50 years ago, and encouraging improvers and managers 
to think broadly about what success constitutes for their 
organisation and hence what should be actually eval-
uated.25 Furthermore, many of the practical guides to 
healthcare quality improvement emphasise the impor-
tance of developing a balanced set of measures during 
the planning of an improvement programme,10 26–28 but 
the focus of such guides is generally on the measure-
ment of goals,29–31 with a smaller number of measures 
for expected undesirable consequences (trade-offs) which 
are easily predictable from the outset. The evidence from 
multiple systematic reviews of quality improvement eval-
uations is that few report any measures of unintended 
consequences,4–7 consistent with almost half of our 
participants having little or no experience of using them, 
despite considerable quality improvement experience 
overall.
The findings of this consensus study reiterate 
and confirm the results of our previous work,2 3 and 
suggest that those involved in improvement programmes 
should first articulate clear assumptions and formulate 
explicit predictions for both goals and trade-offs before 
implementation, and seek to identify relevant process 
and outcome measures for both. Second, an ‘improve-
ment pause’ should be planned after implementation 
to deliberately step back from goal delivery to take stock 
and reflect on unexpected consequences of improve-
ment activity. Unpleasant surprises in particular need to 
be carefully evaluated to see if any harm being caused is 
enough to stop or adapt the intervention to reduce the 
likelihood of any unpleasant surprises both within and 
outwith the area targeted for improvement.
Improvers and managers could anticipate these vulner-
abilities by making careful and continuously planned 
efforts to explore all possible process and/or outcome 
failures both before and after implementation and as 
ongoing surveillance mechanisms. However, all improve-
ment programmes are resource constrained and there 
will always be more risks than can feasibly be measured. 
Moving beyond simply identifying potential conse-
quences, improvers need to reflect on whether measure-
ment is truly meaningful,32 make choices as to what 
identified consequences should be systematically eval-
uated and rationally account for the relative balance of 
risk and benefits. Based on the findings of this study, we 
suggest that this decision should be made by assessing if 
the depth, seriousness and severity of any trade-offs and 
unpleasant surprises in relation to patient care and other 
widespread workload and financial implications are likely 
to be so significant that they warrant particular attention 
to ensure these undesirable consequences are identi-
fied correctly and evaluated thoroughly, and if necessary 
action is taken to mitigate them.
Lack of data to measure unexpected consequences 
remains a significant problem. This is particularly 
common in healthcare systems where electronic health 
records are in limited use or where the usable routine 
data available have limited scope for use in evaluation. 
This is particularly common in healthcare systems where 
electronic health records are in limited use or where 
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the usable data have limited scope. Furthermore, even 
where relevant quantitative data are available retrospec-
tively it will rarely provide a full explanation for what 
happened within or outwith the healthcare system. 
Consistent with other literature,33 34 our participants 
agreed that qualitative data have an important role in 
evaluating surprises directly, as well as contextualising 
quantitative data where these are available. In the (often 
misquoted) words of Deming, ‘It is wrong to suppose 
that if you can’t measure it, you can’t manage it—a costly 
myth’.35
Finally, improvers should think more broadly about 
the stakeholders they involve as different levels of 
engagement can be appropriate for different stages in 
the evaluation process. There was a clear agreement in 
our study that the clinical teams delivering care should 
be involved throughout the whole process, but that 
other stakeholders’ importance varied with the stage of 
improvement. For instance, patients might have a unique 
perspective on care which is often invisible to most profes-
sionals but can usefully inform the identification of wider 
unintended consequences.32 36 37
Managerial staff directly involved in organising the 
targeted care who also understands the implications of 
changes on other parts of the system can play a significant 
role in identifying both intended and unintended conse-
quences and deciding whether measurement is needed 
by aligning the focus on short-term external demands 
with internal priorities and long-term focus on quality 
improvement. However, without interpretation, measure-
ment has little meaning and can be misleading, particu-
larly when unpleasant surprises tend to be under-reported. 
Improvement advisors can, therefore, actively contribute 
to summarising and distilling the data, bringing a body of 
expertise in explicit change theories which are different 
from, but complementary to, the expertise of managers 
and clinicians.
The active involvement of other stakeholders (eg, 
academics, clinical teams outside the targeted area, third 
sector representatives and policy-makers) was perceived 
as relatively important but failed to reach the consensus 
standard, potentially being judged as ‘nice to have, but 
not always crucial’.38 This was particularly surprising in 
relation to academics involvement, whose perceived 
importance was only marginal despite the majority of 
our expert panel having academic links. This lack of 
consensus might reflect the recognised pros and cons of 
using a more rigorous, generalisable, but time-consuming 
research approach as opposed to small-scale, rapid and 
locally responsive quality improvement methods.30 What 
is important to reiterate, is that in practice, improvers 
will have to make decisions appropriate to their own 
context, but we recommend that they actively consider 
these findings when making situational judgements, and 
notably that the development of the research skills of 
local teams might help ensure academic input is viewed 
more favourably.39
COnClusiOn
Based on evidence and consensus opinions of diverse 
stakeholder community, we conclude that a balanced 
approach should consider goals and predictable trade-offs 
early in the design of a quality improvement programme, 
and subsequently pause to take stock of unpleasant 
surprises after a period of implementation. Evaluation 
should be done iteratively during the improvement 
journey and simultaneously with implementation, using 
both qualitative and quantitative methods. Vigilance for 
unexpected consequences should be an ongoing, active 
pursuit for all relevant stakeholders, whose roles in the 
process of identifying, prioritising, evaluating and inter-
preting potential consequences should be explicitly 
addressed within planning and, if required, revisited 
during and after implementation.
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